Photochemistry and Photobiology · 1992 · 49 citations · 14 references
MedicineCancer BiologyPharmacologyCancer PharmacologyCellular PharmacologyMolecular PharmacologyCellular Drug EffluxChemotherapy ResistanceDrug-induced PhotosensitivityPhotodynamic TherapyPorphyrin MetabolismCancer Photodynamic TherapyMitochondrial PhotodamageMultidrug Resistance DeterminantsPhotodamagePhotosensitizersPhotosensitizing CompoundsPorphyrin AccumulationTransporter Alterations
The P388 murine leukemia and P388/ADR, a subline expressing the multi-drug resistance (MDR) phenotype, were examined with regard to the role of MDR as a determinant of responsiveness to photodynamic therapy in vitro. Mesoporphyrin was used as a model substrate. We found no differences in porphyrin accumulation nor transport alterations associated with exposure of P388/ADR cells to the verapamil analog DMDP. There was a significant correlation between photodamage to mitochondria vs loss of cell viability in both cell lines, and LD50 sensitizer levels were not significantly different in P388 vs P388/ADR. P388/ADR cells were partly resistant to porphyrin-catalyzed photodamage to amino acid transport, but this result was not associated with differences in sensitizer localization, as indicated by fluorescence studies. Moreover, photodamage to membrane transport was not associated with loss of viability. These studies suggest that cells which express the MDR phenotype are unlikely to be cross-resistant to photodynamic therapy.
14
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
Makoto Inaba, Harumi Kobayashi, Yoshio Sakurai et al. · PubMed · 1979 · 454 citations
Medicine, Oncology, Pharmacology +17
Effects of photoactivated porphyrins at the cell surface of leukemia L1210 cells
David Kessel · Biochemistry · 1977 · 209 citations · Full text
Pharmacy, Cell Biology, Pharmacology +10